Gilead’s manufacturing facility in Edmonton, located in the Canadian province of Alberta, handles development and manufacturing of investigational drugs, supplies active pharmaceutical ingredients for clinical research programs and contributes to new product launch supplies.
Gilead’s Alberta facility is committed to the development and manufacture of life-saving medicines without adversely affecting the health and safety of its employees, its neighbors, or its environment. For more information about Gilead Alberta’s Environmental Policy, click here.
Gilead Alberta ULC
1021 Hayter Road
Phone: +1 780-701-6400 +1 780-701-6400
Fax: +1 780-472-8189
Gilead’s office in Mississauga, located in the Canadian province of Ontario, provides Administrative, Commercial, Medical, Regulatory, Finance and Legal support for Biktarvy®, Cayston®, Hepsera®, Viread®, Truvada®, Atripla®, Complera®, Stribild®, Sovaldi®, Descovy®, Epclusa™, Genvoya®, Harvoni®, Odefsey™, Vemlidy™ and Zydelig® in Canada.
Voluntary Disclosure of Payments
Divulgation volontaire des paiements
Gilead Sciences Canada, Inc. included in Forbes Canada’s Most Reputable Companies 2017